Healthcare M&A 2026: Q1–Q2 Trends and the Major Provider Deals to Know

# Quick summary Healthcare M&A picked up speed in 2026. Kaufman Hall data cited in the source shows Q1 had more transactions than any of the previous five Q1 results, and Q2 reached the highest M&A levels since 2019. The wave is concentrated among hospitals and regional health systems pursuing scale, ambulatory expansion, and local capital investment.

# What changed in deal activity

# Notable Q2 2026 deals

• Ascension completed a $3.9 billion acquisition of AMSURG, expanding Ascension's network to 300 ambulatory surgery centers. The Federal Trade Commission required divestiture of seven AMSURG locations in five markets. The FTC said the divestitures will help preserve competitive markets and fair pricing. Ascension characterized the deal as expanding ambulatory capabilities while keeping hospitals focused on acute care.

• Sutter Health and Allina Health signed a letter of intent for Allina to join Sutter, with closing expected by year‑end pending regulatory approval. The combined system plans more than $2 billion in investments across Minnesota and western Wisconsin, including new ambulatory sites, AI initiatives, and modernized scheduling. Allina will keep its name, brand, and Minneapolis headquarters as Sutter's Upper Midwest Division.

• Sanford Health and North Memorial Health signed a definitive agreement to combine and expect to create a single nonprofit health system by year‑end. The joint plan includes $600 million in investments for Robbinsdale and Maple Grove hospitals. Leadership emphasizes maintaining Robbinsdale as a Level 1 trauma and emergency provider and expanding outpatient capacity in growing communities.

• CommonSpirit agreed to sell Ohio's Trinity Health System to UPMC, with the transaction expected to close in fall 2026 pending regulatory review. Statements framed the move as aligning mission and community service priorities between the organizations.

# What to watch next

• Local capital commitments: Multiple transactions include multi‑hundred‑million to multi‑billion dollar investments targeted at hospital redevelopment, ambulatory expansion, and workforce growth. Monitor how those commitments are executed and whether they produce measurable access improvements.

• Integration priorities: Deals emphasize ambulatory capacity, digital and AI investments, and modernized scheduling. The effectiveness of these integrations will determine whether acquisitions deliver intended operational and patient‑access benefits.

# Bottom line The first half of 2026 saw a measurable uptick in healthcare M&A, dominated by hospital systems consolidating regionally and investing in ambulatory services and local infrastructure. Regulatory review and the practical challenges of integration will shape the ultimate outcomes of these transactions.